Project: Development of microfluidics cartridge for next-generation point-of-care devices
We will develop the next generation platform for point of care (POC) diagnostics. BluSense is developing SenseLab, a POC device for high sensitivity immunoassays employing a novel detection technology. The business model is based on selling single use cartridges, which will be developed in this project. The consortium has in depth knowledge about development and large scale production of microfluidic consumables. We will deliver a simple to use, low cost cartridge for Diabetes type 2 monitoring.
| Acronym | DIADEM (Reference Number: 9858) |
| Duration | 01/07/2015 - 01/04/2017 |
| Project Topic | Biological Sciences / Technologies |
| Network | Eurostars 2 |
| Call | Eurostars Cut-Off 3 |